News: Emily Chan

Colon Cancer Added to Gene Mutation Testing

Thursday, July 19th, 2012

Vanderbilt-Ingram Cancer Center has initiated tumor mutation testing for a limited number of patients with metastatic colorectal cancer. This pilot project for colorectal cancer is part of VICC’s Personalized Cancer Medicine Initiative (PCMI), a program to identify genetic mutations in a patient’s tumor that may be useful in matching the appropriate therapy with each patient. […]

Pancreatic Cancer, Genetics and Family History

Monday, November 21st, 2011

Dr. Emily Chan, a medical oncologist at Vanderbilt-Ingram Cancer Center, discusses hereditary pancreatic cancer and what is done to follow those showing concerns of developing the cancer. She encourages patients to research clinical trials since the current therapies for pancreatic cancer need improvement.